In vitro assessment of plasma protein binding of 20(R)-ginsenoside Rh2 by equilibrium dialysis and LC-MS analysis: A case of species differences

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 5, 2006, Pages 951-956

  Gu, Yi ^a   Wang, Guangji ^a   Sun, Jianguo ^a   Jia, Yuanwei ^a   Xu, Meijuan ^a   Wang, Wei ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

20(R) ginsenoside Rh2; Equilibrium dialysis; LC MS; Plasma protein binding

Indexed keywords

GINSENOSIDE; GINSENOSIDE RH 2; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; DRUG DISTRIBUTION; DRUG STRUCTURE; EQUILIBRIUM DIALYSIS; HUMAN; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PLASMA PROTEIN BINDING; RAT;

ANIMALS; BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; DIALYSIS; GINSENOSIDES; HUMANS; INDICATORS AND REAGENTS; MASS SPECTROMETRY; MEMBRANES, ARTIFICIAL; PROTEIN BINDING; RATS; REPRODUCIBILITY OF RESULTS; SPECIES SPECIFICITY;

EID: 33646464991     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.951     Document Type: Article

References (20)

1. Attele A. S., Wu J. A., Yuan C. S., Biochem. Pharmacol., 58, 1685-1693 (1999).
2. Xu J. D., Ren Shen Yan Jiu, 1, 2-7 (1996).
3. Park J. A., Lee K. Y., Oh Y. J., Kim K. W., Lee S. K., Cancer Lett., 121, 73-81 (1997).
4. Kim H. E., Oh J. H., Lee S. K., Oh Y. J., Life Sci., 65, PL33-PL40 (1999).
5. Ham Y. M., Chun K. H., Choi J. S., Kim D. H., Lee S. K., Biochem. Biophys. Res. Commun., 304, 358-364 (2003).
6. Tatsuka M., Maeda M., Ota T., Jpn. J. Cancer Res., 92, 1184-1189 (2001).
7. Lee Y. N., Lee H. Y., Chung H. Y., Kim S. I., Lee S. K., Park B. C., Eur. J. Cancer, 32A, 1420-1428 (1996).
8. Nakata H., Kikuchi Y., Tode T., Hirata J., Kita T., Ishii K., Jpn. J. Cancer Res., 89, 733-740 (1998).
9. Fei X. F., Wang B. X., Tashiro S., Li T. J., Ma J. S., Ikejima T., Acta Pharmacol. Sin., 23, 315-322 (2002).
10. Cheng C. C., Yang S. M., Huang C. Y., Chen J. C., Chang W. M., Hsu S. L., Cancer Chemother. Pharmacol., 55, 531-540 (2005).
11. Xie H. T., Wang G. J., Lv H., Wang R., Sun J. G., Jiang X. L., Eur. J. Drug Metab. Pharmacokinet., 30, 63-67 (2005).
12. Fuzzati N., J. Chromatogr. B, 812, 119-133 (2004).
13. Sun J., Wang G., Xie H. T., Li H., Pan G. Y., Tucker I., J. Pharm. Biomed. Anal., 38, 126-132 (2005).
14. Lu L., Jiang X., Yang J., Zhou J., Western China J. Pharm. Sci., 18, 246-250 (2003).
15. Endo H., Yoshida H., Hasegawa M., Ohmi N., Houriuchi N., Hamada Y., Biol. Pharm. Bull., 24, 800-805 (2001).
16. Yoshida K., Mitani M., Naeshiro I., Torii H., Tanayama S., Antimicrob. Agents Chemother., 29, 1017-1024 (1986).
17. Tanayama S., Yoshida K., Adachi K., Konado T., Antimicrob. Agents Chemother., 18, 511-518 (1980).
18. Bae E., Han M. J., Choo M. K., Park S. Y., Kim D. H., Biol. Pharm. Bull., 25, 58-63 (2002).
19. Bae E., Han M. J., Kim E. J., Kim D. H., Arch. Pharm. Res., 27, 61-67 (2004).
20. Jeong S. M., Lee J. H., Kim J. H., Lee B. H., Yoon I. S., Lee J. H., Mol. Cells, 18, 383-389 (2004).